U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06942104) titled 'Imaging of Solid Tumors Using 18F-TRX' on April 16.
Brief Summary: This phase I trial tests the safety and effectiveness of 18F-TRX in detecting tumors (cancer) patients with solid tumors. 18F-TRX is an imaging tracer that is used to visualize tumors using a PET scan. It specifically targets and detects labile (unstable) iron levels within tissues, including tumors. Diagnostic procedures, such as 18F-TRX PET/CT or PET/MRI, may help detect tumors in patients with solid tumors
Study Start Date: May 31
Study Type: INTERVENTIONAL
Condition:
Solid Tumor
Solid Carcinoma
Castration-Resistant Prostate Carcinoma
Locally Advanced Clear C...